GlassScriptPhysician profile
Vincent J Leone
NPI 1487667739
$158,686.01
in general payments reported to CMS, 2019-2025
11 companies · $12K in 2025
The $12K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49K · 2020: $32K · 2021: $3,188 · 2022: $30K · 2023: $20K · 2024: $12K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $42K · Travel and Lodging: $1,387 · Food and Beverage: $1,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $41,752.56 |
| Travel and Lodging | $1,386.95 |
| Food and Beverage | $1,039.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $67,092.62 | 2019-2022 | |
| Zimvie INC. | $38,546.10 | 2022-2023 | |
| Highridge Medical LLC | $23,490.30 | 2024-2025 | Roi-A |
| Choice Spine, LLC | $10,201.02 | 2019-2020 | |
| Ulrich Medical USA, INC. | $6,658.75 | 2019-2021 | |
| Corelink, LLC | $5,686.62 | 2019-2023 | |
| Cerapedics INC. | $4,283.53 | 2022-2025 | I-Factor Peptide Enhanced Bone Graft |
| Medtronic, INC. | $2,125.34 | 2023-2024 | Cd Horizon Spinal System, Mazor X System, Infinity Occipitocervical Upper Thoracic System |
| Seaspine Orthopedics Corporation | $291.68 | 2021-2022 | |
| 4web, INC. | $201.32 | 2020-2024 | Spine Truss System |
| Surgalign Spine Technologies, INC. | $108.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Leone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.